Wentworth Kerry, Chief Regulatory Officer at Nuvation Bio Inc. ($NUVB), made two open market purchases totaling nearly $90,000 in the last year. The most recent buy occurred on June 16, 2025. These purchases rank 2,498th among 4,983 insiders, below the average of about $1.5 million per buyer and 3.3 transactions. Kerry reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 17, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | M | Class A Common Stock | 36750 | $2.93 | 89,750.0000 | 342,833,433 | 69.34% | 0.01% |
| April 17, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | M | Stock Option (Right to Buy) | 36750 | $0.00 | 215,250.0000 | 342,833,433 | 14.58% | 0.01% |
| April 17, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | S | Class A Common Stock | 36750 | $5.01 | 53,000.0000 | 342,833,433 | 40.95% | 0.01% |
| April 6, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | M | Class A Common Stock | 100000 | $1.94 | 253,000.0000 | 342,833,433 | 65.36% | 0.03% |
| April 6, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | M | Class A Common Stock | 100000 | $1.87 | 153,000.0000 | 342,833,433 | 188.68% | 0.03% |
| April 6, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | S | Class A Common Stock | 200000 | $4.52 | 53,000.0000 | 342,833,433 | 79.05% | 0.06% |
| April 6, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | M | Stock Option (Right to Buy) | 100000 | $0.00 | 400,000.0000 | 342,833,433 | 20.00% | 0.03% |
| April 6, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | M | Stock Option (Right to Buy) | 100000 | $0.00 | 300,000.0000 | 342,833,433 | 25.00% | 0.03% |
| Feb. 27, 2026 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| June 16, 2025 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | P | Class A Common Stock | 24000 | $1.80 | 50,000.0000 | 337,678,855 | 92.31% | 0.01% |
| June 16, 2025 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | P | Class A Common Stock | 26000 | $1.79 | 26,000.0000 | 337,678,855 | 9999.99% | 0.01% |
| Feb. 28, 2025 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Nuvation Bio Inc. | $NUVB | Wentworth Kerry | Chief Regulatory Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |